AMD

The study is now expected to be fully enrolled with all 300 patients randomized by the end of 2024.

Related macular dystrophies (MDs) include Sorsby’s fundus dystrophy, Doyne honeycomb macular dystrophy, and autosomal dominant radial drusen.

Iris freckles are the most common melanocytic iris lesions, and UV sunlight is a well-known promoter of melanogenesis. Another study reported a higher rate of iris freckles in patients with UV-associated skin cancer.

The study looked at bevemipretide, which targets the inner mitochondrial membrane where it reversibly binds to cardiolipin.

Jeffry Gerson, OD, FAAO, gives his golden rules on retinal management in two presentations.

Mark Dunbar, OD, FAAO, details a presentation he gave alongside Rishi Singh, MD, on geographic atrophy at Vision Expo West 2024.

By identifying progressive GA earlier, primary eye care providers can make timely referrals and save patients’ visual function.

Understanding the latest innovative technologies.

Comanagement is a key component for treatment of disease.

The new smart glasses utilize artificial intelligence to visually assist those with age-related macular degeneration and other retinal disorders causing vision loss.

The trial will evaluate repeat dosing of axitinib intravitreal implant, (AXPAXLI) for the treatment of patients with wet AMD.

A new analysis by researchers at the National Institutes of Health shows the benefit of taking AREDS2 formula in late AMD.

The 2-year Phase III data demonstrates Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema and diabetic retinopathy.

The company also submitted a marketing authorization application with the European Medicines Agency.

Notal Vision’s device was given to 15 patients to track changes in their neovascular age-related macular degeneration for the study.

Apellis will seek re-examination from the CHMP following the opinion, according to a news release.

The company expects enrollment of the GAZE phase 1, open-label clinical trial, to begin in the second half of 2024.

Respecting the clinical importance of the pachychoroid spectrum is vital when analyzing OCT scans.

Rafieetary emphasizes the importance of follow-up plans and consistent support to prevent patients from dropping out of treatment, which can negatively impact their prognosis.

Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36 months of both continuous monthly and every-other-month treatment.

Researchers examined data of more than 200,000 people, 121,523 of which had no history of AMD.

The biotechnology company is developing the first protein-based artificial retina for patients with retinitis pigmentosa and age-related macular degeneration.

The COAST and ShORe trials have a total of 1984 patients enrolled for the treatment of wet age-related macular degeneration.

The study evaluated the effects of long-term, low-dose aspirin administration in over 3000 older adults.

Aflibercept-jbvf and aflibercept-yszy are the first interchangeable biosimilars to aflibercept 2 mg that have been approved in the US.